Serotonin Involvement in the Basal Ganglia Pathophysiology: Could the 5-HT2C Receptor be a New Target for Therapeutic Strategies?

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|13|25|3069-3081

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.25, 2006-10, pp. : 3069-3081

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insights into the structure and function of 5-HT2 family serotonin receptors reveal novel strategies for therapeutic target development

By Shapiro David A   Roth Bryan L  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 6, 2001-12 ,pp. : 685-695

Informa Healthcare

Access to resources Recommend Favorite

Selective Agents for Serotonin2C (5-HT2C) Receptor

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 18, 2006-09 ,pp. : 1927-1970

Bentham Science Publishers

Access to resources Recommend Favorite

5-HT1A Receptor, an Old Target for New Therapeutic Agents

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 12, 2008-01 ,pp. : 1024-1034

Bentham Science Publishers

Access to resources Recommend Favorite

EMD 281014, a new selective serotonin 5-HT 2A receptor antagonist

By Bartoszyk G.D.   van Amsterdam C.   Bottcher H.   Seyfried C.A.  

European Journal of Pharmacology, Vol. 473, Iss. 2, 2003-07 ,pp. : 229-230

Elsevier

Access to resources Recommend Favorite

New 5-HT2C receptor agonists

By Bishop Michael J   Nilsson Björn M  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 11, 2003-11 ,pp. : 1691-1705

Informa Healthcare

Access to resources Recommend Favorite